ALIOTH7 CONSULTING LIMITED
Company number 12517470 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
ALIOTH7 CONSULTING LIMITED - Analysis Report
Company Number: 12517470
Analysis Date: 2025-07-29 14:18 UTC
Financial Health Assessment for ALIOTH7 CONSULTING LIMITED
1. Financial Health Score: D
Explanation:
The company’s financial health has markedly deteriorated in the latest financial year ending March 2024 compared to prior years. Key liquidity and net asset measures have shrunk substantially, indicating symptoms of financial distress. While still solvent on paper, the sharp decline in cash and net assets signals an underlying weakness that requires urgent attention.
2. Key Vital Signs
| Metric | 2024 Value (£) | 2023 Value (£) | Interpretation |
|---|---|---|---|
| Current Assets | 2,116 | 21,872 | Severe reduction in liquid assets and debtors; cash depleted to zero from £18,747 in prior year. |
| Cash at Bank | 0 | 18,747 | Critical symptom of liquidity crisis; no cash reserves available to meet immediate obligations. |
| Current Liabilities | 1,485 | 12,757 | Current liabilities sharply reduced, possibly through repayment or restructuring. |
| Net Current Assets | 631 | 9,115 | Working capital severely contracted, but still positive – a faint sign of short-term solvency. |
| Net Assets (Shareholders’ Funds) | 725 | 9,304 | Drastic decline in equity base (~92% drop), indicating erosion of retained earnings and capital. |
| Debtors | 2,116 | 3,125 | Declining trade receivables, possibly due to reduced sales activity or tighter credit control. |
| Tangible Fixed Assets | 94 | 189 | Minimal fixed assets, declining slightly—no significant investment in long-term resources. |
| Director Advances (Net Debtor) | 1,466 | 11,995 | Director loan reduced substantially, indicating partial repayment or write off. |
Summary:
The company’s liquidity — its "pulse" — is weak, with cash reserves exhausted. The "net current assets" (working capital) remain positive but have shrunk sharply, suggesting the company could struggle to meet short-term demands if the trend continues. The equity "vital signs" reveal a serious loss of retained profits, pointing towards operational challenges or losses in recent periods.
3. Diagnosis: Financial Condition Assessment
Liquidity Symptoms: The complete depletion of cash at bank is an alarming symptom akin to a patient running a high fever—it signals acute financial stress. While current liabilities have reduced, the lack of cash to cover immediate expenses raises concerns over operational continuity.
Capital Erosion: The equity base has diminished dramatically, signaling accumulated losses or distributions that have not been replenished. This is comparable to a weakening immune system, reducing the company’s ability to absorb shocks.
Trading Activity: The decline in debtors and overall current assets suggests a contraction in business activity or tighter credit terms. The absence of employees (average number employed is zero during the year) hints at a possible pause or scaling down in operations.
Director Loan Movements: The reduction in director advances from nearly £12,000 to £1,466 could indicate repayment efforts or impairment, reflecting attempts to stabilize finances.
Asset Base: Tangible fixed assets are minimal and depreciating, showing no capital investment for growth or replacement, which may impair future earning capacity.
Overall Diagnosis:
The company shows symptoms of financial distress, primarily due to liquidity exhaustion and capital erosion. While technically solvent with positive net assets and working capital, the sharp declines signal a fragile state. Without corrective action, these symptoms could escalate into a full-blown financial crisis.
4. Recommendations: Improving Financial Wellness
Immediate Cash Flow Management:
- Prioritize generating or securing cash inflows through accelerated collections, new financing, or director/investor injections.
- Negotiate extended payment terms with creditors to ease immediate cash outflows.
Operational Review:
- Assess the current business model and revenue streams to identify causes of declining activity.
- Reconsider cost structures, including fixed and variable costs, aiming for lean operations aligned with current demand.
Capital Structure Strengthening:
- Consider equity injections or refinancing to rebuild shareholder funds and restore financial resilience.
- Explore government grants, loans, or support schemes for consultancy businesses if eligible.
Director and Stakeholder Engagement:
- Maintain transparent communication with directors and shareholders about the financial status and recovery plans.
- Utilize director advances effectively to support liquidity shortfalls if possible.
Financial Monitoring:
- Establish rigorous monthly cash flow forecasting and financial reporting to detect and react promptly to financial distress signals.
Strategic Planning:
- Develop a turnaround or growth strategy that addresses declining revenues and asset utilization.
- Explore market opportunities within the engineering consulting sector to revive business momentum.
Medical Analogy Summary:
ALIOTH7 CONSULTING LIMITED is currently exhibiting "symptoms of distress" with a "weak pulse" in cash flow and a "shrinking immune system" in its equity base. Without urgent "treatment" — cash flow intervention and capital reinvigoration — the company risks slipping from a fragile state into financial insolvency.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.